Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. [electronic resource]
Producer: 20130328Description: 1260-7 p. digitalISSN:- 1538-3598
- Aged
- Anti-Bacterial Agents -- administration & dosage
- Bronchiectasis -- complications
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Resistance, Bacterial
- Erythromycin -- administration & dosage
- Female
- Humans
- Lung -- physiopathology
- Male
- Middle Aged
- Pseudomonas Infections -- etiology
- Pseudomonas aeruginosa -- isolation & purification
- Respiratory Tract Infections -- etiology
- Sputum -- microbiology
- Streptococcus -- isolation & purification
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.